Converus Stock

Converus provides scientifically validated credibility assessment technologies.

Sign up today and learn more about Converus Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Converus Stock

Converus provides scientifically validated credibility assessment technologies that help protect countries, corporations, and communities from corruption, crime, and threats. Today, Converus offers 3 main products. It has developed a technology called EyeDetect that detects deception by scanning the human eye in a non-invasive manner. Converus also offers a product called IdentityDetect, a quick and simple web-based test or mobile app that can quickly verify a person’s identity. While it IntegrityDetect is a unique integrity-assessment test designed to replace the traditional integrity test.

Funding History

March 2013$1.3M
November 2014$1.4M
January 2017$3.9M


VP Marketing and Operations

Russ Warner

President & CEO

Todd Mickelsen

Chief Technology Officer

Ben Stout

Chief Software Architect

Greg Parkinson

Vice President, Corporate Communications

Jeff Pizzino

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: